This agrees with Zinellu & Mangoni, 2021 who found low serum level of C3 and C4 suggesting more complement activation and product consumption, which is substantially associated with severe illness and higher mortality in COVID-19 patients [47]. The gene discussed is C4A; the disease is COVID-19.